Skip to main content
Fig. 2 | BMC Anesthesiology

Fig. 2

From: Clinical characteristics, risk factors, immune status and prognosis of secondary infection of sepsis: a retrospective observational study

Fig. 2

Biomarkers of immune status in septic patients stratified according to developing secondary infection or not. Data of a part of patients were available for HLA-DR expression and cytokines and the exact numbers were shown in Table 1. Data were presented as medians (shown as triangles or circles) and 25- and 75- percentile error bars. Exceptions were mean and standard deviation error bars were used in HLA-DR expression at day 1 and IL-10 level at day 7. a and b represented the levels and dynamic changes of two anti-inflammatory biomarkers (HLA-DR and IL-10) respectively. c and d represented the levels and dynamic changes of two pro-inflammatory biomarkers (IL-6 and IL-8) respectively. * P < 0.05, ** P < 0.01, *** P < 0.001. SI, secondary infection; NSI, non-secondary infection

Back to article page